Logo KMS TEAM
Precise execution

MC Services is...

Client News

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

read more

MC Services supported companies and media representatives at the German Equity Forum

The German Equity Forum is Europe's largest capital market event for corporate finance and a central matching platform for senior company representatives from various industries and the financial community. It took place from Monday to Wednesday, 24 to 26 November 2014, at the Congress Center and Hall 5.1 of Messe Frankfurt.

 

MC Services AG was again coordinating, as a sponsor of the German Equity Forum, the event's press lounge from November 25 to 26 2014. We presented an exclusive working and communications platform with interview areas and workstations for journalists. In addition, we  introduced a wealth of companies and clients in the healthcare/biotech panels, as well as moderated the Q&A sessions following their presentations.


Please also follow us on Twitter (@MCServicesAG; #MCPressLounge).

ORYX' Therapeutic Vaccine MicOryx Successfully Completes Phase I/IIa Trial to Treat MSH-H Colorectal Cancer

www.oryx-medicine.com

NanoRepro AG stärkt Präsenz in Deutschland durch Kauf der Marke alphabiol

www.nano.ag

SYGNIS AG signs initial distribution agreement for the Asian market for the TruePrime™ product family with Japanese Funakoshi Co. Ltd.

www.sygnis.com

NEOVACS SCIENTIFIC ADVISORY BOARD ENDORSES COMPANY'S UPDATED IFNα-KINOID DEVELOPMENT PLAN

www.neovacs.fr

ORYX to Present at Sachs European Life Science CEO Forum and Exhibition

www.oryx-medicine.com

Medigene to participate in three upcoming international conferences

www.medigene.com

ImevaX welcomes KfW to investor syndicate in second closing of Series A financing

www.imevax.com

FINANCIAL RESULTS FOR 2014 - FY2014 in line with Company expectations

www.neovacs.fr

MorphoSys AG Reports Results for Fiscal Year 2014

www.morphosys.com

GBC Research nimmt Analysten-Coverage von NanoRepro AG auf und gibt Kaufempfehlung mit einem Kursziel von 2,05 Euro pro Aktie

www.nano.ag

WILEX subsidiary Heidelberg Pharma receives research grant from the European Union

www.wilex.de

NanoRepro AG plant Barkapitalerhöhung mit Bezugsrecht

www.nano.ag